Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Five Takeaways From Commissioner Gottlieb's Talk At The National Press Club

Nov 07 2017

• By Ferdous Al-Faruque

FDA commissioner Scott Gottlieb — Scott Gottlieb

Related Content

FDA's Opioid Programs: After Training, What's The Next Step?

Oct 05 2017

OMB: US FDA Has Withdrawn At least 10 Regulations In Response To Trump 2-for-1 Order

Oct 06 2017

Opioid Use Disorder App Marks A Path For 510(k) 'Breakthrough' Devices

Oct 27 2017

Established Heart Survey Clinches First MDDT Qualification

Oct 25 2017

For Some Companies, Puerto Rico Financial Impact Uncertain

Nov 03 2017

'Super Office' To The Rescue: FDA's Device Center Is About To Undergo A 'Total Product Life Cycle' Makeover

Sep 29 2017

Related Companies

Pearl Therapeutics, Inc.

Additional Topics

United States Regulation FDA Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window